SPOTLIGHT -
EP. 1: Global Trends in HCC Risk Factors
EP. 2: Screening for HCC: Current and Emerging Biomarkers
EP. 3: Diagnosing HCC: When a Biopsy is Needed
EP. 4: Understanding BCLC Criteria in Liver Cancer Staging
EP. 5: Impact of Liver Cirrhosis in HCC
EP. 6: Risk/Benefit of Expanding Liver Transplant Criteria
EP. 7: Ablation vs Resection in Liver Cancer
EP. 8: Initial Approaches in Locally Advanced HCC
EP. 9: Frontline SIRT vs Systemic Therapy in HCC
EP. 10: Transitioning to Systemic Therapy in HCC
EP. 11: HCC: Managing Patients on Frontline Systemic Therapy
EP. 12: Second-Line Systemic Therapy in HCC
EP. 13: Frontline Lenvatinib vs Sorafenib in HCC
EP. 14: Emerging Approaches in Liver Cancer
Dr Berkenstock on ADC-Related Ocular Toxicities in Cervical and Ovarian Cancers
Dr Matalonis on the Management of Mirvetuximab Soravtansine-Related Toxicities in FRα+ Ovarian Cancer
Updated EMPOWER-Lung 3 Data Support Frontline Cemiplimab Plus Chemo in Advanced NSCLC
Neoadjuvant Nivolumab Plus Chemotherapy Retains EFS Advantage in Resectable NSCLC
